237 related articles for article (PubMed ID: 32467311)
1. A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival.
Qiu Y; Lyu J; Dunlap M; Harvey SE; Cheng C
RNA; 2020 Sep; 26(9):1257-1267. PubMed ID: 32467311
[TBL] [Abstract][Full Text] [Related]
2. Prediction of RNA-binding protein and alternative splicing event associations during epithelial-mesenchymal transition based on inductive matrix completion.
Qiu Y; Ching WK; Zou Q
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33517359
[TBL] [Abstract][Full Text] [Related]
3. PCB: A pseudotemporal causality-based Bayesian approach to identify EMT-associated regulatory relationships of AS events and RBPs during breast cancer progression.
Sun L; Qiu Y; Ching WK; Zhao P; Zou Q
PLoS Comput Biol; 2023 Mar; 19(3):e1010939. PubMed ID: 36930678
[TBL] [Abstract][Full Text] [Related]
4. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
Harvey SE; Xu Y; Lin X; Gao XD; Qiu Y; Ahn J; Xiao X; Cheng C
RNA; 2018 Oct; 24(10):1326-1338. PubMed ID: 30042172
[TBL] [Abstract][Full Text] [Related]
5. Matrix factorization-based data fusion for the prediction of RNA-binding proteins and alternative splicing event associations during epithelial-mesenchymal transition.
Qiu Y; Ching WK; Zou Q
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410342
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line.
Mi Y; Dong M; Zuo X; Cao Q; Gu X; Mi H; Xiao F
Sci Rep; 2024 May; 14(1):11753. PubMed ID: 38783078
[TBL] [Abstract][Full Text] [Related]
7. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
Elife; 2018 Jul; 7():. PubMed ID: 30059005
[TBL] [Abstract][Full Text] [Related]
8. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.
Shapiro IM; Cheng AW; Flytzanis NC; Balsamo M; Condeelis JS; Oktay MH; Burge CB; Gertler FB
PLoS Genet; 2011 Aug; 7(8):e1002218. PubMed ID: 21876675
[TBL] [Abstract][Full Text] [Related]
9. Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition.
Yang Y; Park JW; Bebee TW; Warzecha CC; Guo Y; Shang X; Xing Y; Carstens RP
Mol Cell Biol; 2016 Jun; 36(11):1704-19. PubMed ID: 27044866
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing.
Hu X; Harvey SE; Zheng R; Lyu J; Grzeskowiak CL; Powell E; Piwnica-Worms H; Scott KL; Cheng C
Nat Commun; 2020 Jan; 11(1):486. PubMed ID: 31980632
[TBL] [Abstract][Full Text] [Related]
11. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
Vadlamudi Y; Dey DK; Kang SC
Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Alternative Splicing during Epithelial-Mesenchymal Transition.
Lyu J; Cheng C
Cells Tissues Organs; 2022; 211(2):238-251. PubMed ID: 34348273
[TBL] [Abstract][Full Text] [Related]
13. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
Wang D; Haley JD; Thompson P
BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
[TBL] [Abstract][Full Text] [Related]
14. Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.
Fici P; Gallerani G; Morel AP; Mercatali L; Ibrahim T; Scarpi E; Amadori D; Puisieux A; Rigaud M; Fabbri F
Oncotarget; 2017 Jan; 8(2):2423-2436. PubMed ID: 27911856
[TBL] [Abstract][Full Text] [Related]
15. Splicing factor
Gökmen-Polar Y; Neelamraju Y; Goswami CP; Gu Y; Gu X; Nallamothu G; Vieth E; Janga SC; Ryan M; Badve SS
EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30665944
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.
Luo BP; Luo J; Hu YB; Yao XW; Wu FH
Curr Med Sci; 2018 Jun; 38(3):467-472. PubMed ID: 30074214
[TBL] [Abstract][Full Text] [Related]
17. A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer.
Elhasnaoui J; Ferrero G; Miano V; Franchitti L; Tarulli I; Coscujuela Tarrero L; Cutrupi S; De Bortoli M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887187
[TBL] [Abstract][Full Text] [Related]
18. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
Göttgens EL; Span PN; Zegers MM
Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
[TBL] [Abstract][Full Text] [Related]
20. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]